Crossmark

Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12967-023-04226-z

Published Online: 2023-06-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jinushi, Ryuhei http://orcid.org/0000-0002-0422-6723
Masuda, Sakue

Tanisaka, Yuki

Nishiguchi, Sho

Shionoya, Kento

Sato, Ryo

Sugimoto, Kei

Shin, Takahiro

Shiomi, Rie

Fujita, Akashi

Mizuide, Masafumi

Ryozawa, Shomei
Clinical Trials ^BETA

Clinical trials referenced in this document:

umin000050465 at UMIN Japan

Documents that mention this clinical trial

Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis
https://doi.org/10.1186/s12967-023-04226-z
License Information

Text and Data Mining valid from 2023-06-19

Version of Record valid from 2023-06-19
More Information

Article History

Received: 30 March 2023

Accepted: 25 May 2023

First Online: 19 June 2023

Declarations

:

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below